Detalhe da pesquisa
1.
A universal MHCII technology platform to characterize antigen-specific CD4+ T cells.
Cell Rep Methods
; 3(1): 100388, 2023 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814840
2.
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.
Cancer Cell
; 40(9): 1010-1026.e11, 2022 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36027916
3.
Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.
Nat Commun
; 11(1): 661, 2020 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005826